Evaluation ofantibacterial and anti-biofilm activities of cinchona alkaloid derivatives against Staphylococcus aureus

Natural Product Communications

Volumn 7, Issue 9, 2012, Pages 1173-1176

  Skogman, Malena E ^a   Kujala, Janni ^a   Busygin, Igor ^a,b   Leino, Reko ^a   Vuorela, Pia M ^a   Fallarero, Adyary ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b BASF SE   (Germany)

Author keywords

Antimicrobial; Biofilms; ChemGPS NP; Cinchona alkaloid; Fluorescence microscopy; Staphylococcus aureus

Indexed keywords

11 TRIPHENYLSILYL 10,11 DIHYDROCINCHONIDINE; CINCHONA ALKALOID; CINCHONIDINE; CINCHONINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIABILITY; BIOFILM; BIOMASS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG TOLERABILITY; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); CINCHONA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CINCHONA ALKALOIDS; STAPHYLOCOCCUS AUREUS;

EID: 84866745520     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. (a) Steinberger RE, Holden PA. (2005) Extracellular DNA in single- and multiple-species unsaturated biofilms. Applied and Environmental Microbiolology, 71, 5404-5410;
2. (b) Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. (2010) Antibiotic resistance of bacterial biofilms. International Journal of Antimicrobial Agents, 35, 322-332;
3. (c) O'Gara JP (2007) ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiology Letters, 270, 179-188.
4. (a) Landini P, Antoniani D, Burgess J, Nijland R. (2010) Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Applied Microbiology and Biotechnology, 86, 813-823;
5. (b) Newman DJ, Cragg GM. (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, Feb 8. [Epub ahead of print];
6. (c) Verpoorte R, Schripsema J, Van der Leer T (1988) Cinchona alkaloids. In The Alkaloids, chemistry and physiology. Brossi A. (Ed.). Academic Press, Inc., San Diego, California, USA. 331-398.
7. Ridley RG. (2002) Medical need, scientific opportunity and the drive for antimalarial drugs. Nature, 415, 686-693.
8. Kharal SA, Hussain Q, Ali S, Fakhuruddin (2009) Quinine is bactericidal. The Journal of the Pakistan Medical Association, 59, 208-212.
9. Lv J, Qian Y, Liu T, Wang Y. (2007) Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus. Bioorgic & Medicinal Chemistry Letters, 17, 4102-4106. (Pubitemid 47033888)
10. Andersson MI, MacGowan AP. (2003) Development of the quinolones. Journal of Antimicrobials and Chemotherapy, 51, 1-11. (Pubitemid 36622099)
11. Lewis K. (2001) Riddle of biofilm resistance. Antimicrobial Agents and Chemotherapy, 45, 999-1007.
12. (a) Chai Y, Liu ML, Lu K, Feng LS, Li SJ, Sun LY, Wang S, Guo HY. (2011) Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives. European Journal of Medicinal Chemistry, 46, 4267-4273;
13. (b) Knauer A, Sirichaisinthop J, Reinthaler FF, Wiedermann G, Wernsdorfer G, Wernsdorfer WH. (2003) In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand. Wiener Klinische Wochenschrift, 115, Suppl 3, 39-44;
14. (c) Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. (2000) A modified microtiter-plate test for quantification of staphylococcal biofilm formation. Journal of Microbiological Methods, 40, 175-179. (Pubitemid 30107900)
15. Mariscal A, Lopez-Gigosos R, Carnero-Varo M, Fernandez-Crehuet J. (2009) Fluorescent assay based on resazurin for detection of activity of disinfectants against bacterial biofilm. Applied Microbiology and Biotechnology, 82, 773-783.
16. (a) Saginur R, St. Denis M, Ferris W, Aaron S, Chan F, Lee C, Ramotari K. (2006) Multiple combination bactericidal testing of Staphylococcal biofilms from implant- associated infections. Antimicrobial Agents and Chemotherapy, 50, 55-61;
17. (b) Brooun A, Liu S, Lewis K. (2000) A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy, 44, 640-646. (Pubitemid 30117954)
18. (a) Anderl JN, Franklin MJ, Stewart PS. (2000) Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrobial Agents and Chemotherapy, 44, 1818-1824;
19. (b) Cecchetti V, Fravolini A, Lorenzini MC, Tabarrini O, Terni P, Xin T. (1996) Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. Journal of Medicinal Chemistry, 39, 436-445;
20. (c) Zhao X, Wang JY, Xu C, Dong Y, Zhou J, Domagala J, Drlica K. (1998) Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrobial Agents and Chemotherapy, 42, 956-958;
21. (d) Pitts B, Hamilton M, Zelver N, Stewart P. (2003) A microtiter-plate screening method for biofilm disinfection and removal. Journal of Microbiological Methods, 54, 269-276. (Pubitemid 36629539)
22. (a) Larsson J, Gottfries J, Muresan S, Backlund A. (2007) ChemGPS-NP: tuned for navigation in biologically relevant chemical space. Journal of Natural Products, 70, 789-794;
23. (b) Rosén J, Lövgren A, Kogej T, Muresan S, Gottfries J, Backlund A. (2009) ChemGPS-NP(Web): chemical space navigation online. Journal of Computer-Aided Molecular Design, 23, 253-259;
24. (c) Toté K, Berghe DV, Deschacht M, de Wit K, Maes L, Cos P. (2009) Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. International Journal of Antimicrobial Agents, 33, 525-531;
25. (d) Burton E, Yakandawala N, LoVetri K, Madhyastha M. (2007) A microplate spectrofluorometric assay for bacterial biofilms. Journal of Industrial Microbiology & Biotechnology, 34, 1-4;
26. (a) Kaplan JB, Ragunath C, Ramasubbu N, Fine DH. (2003) Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. Journal of Bacteriology, 185, 4693-4698;
27. (b) Busygin I, Toukoniitty E, Sillanpää R, Yu Murzin D, Leino R. (2005) Synthesis of chiral catalyst modifiers by hydrosilylation of cinchonidine and their application in the hydrogenation of 1-phenylpropane-1,2- dione and ethyl pyruvate on a supported Pt/Al2O3 catalyst. European Journal of Organic Chemistry, 2811-2821. (Pubitemid 40976846)
28. Sandberg ME, Schellmann D, Brunhofer G, Erker T, Busygin I, Leino R, Vuorela PM, Fallarero A. (2009) Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilms in a screening assay. Journal of Microbiological Methods, 78, 104-106.
29. Sandberg M, Määttänen A, Peltonen J, Vuorela P, Fallarero A. (2008) Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds. International Journal of Antimicrobial Agents, 32, 233-240
30. Karlsson D, Fallarero A, Brunhofer G, Mayer C, Prakash O, Mohan CG, Vuorela P, Erker T. (2012) The exploration of thienothiazines as selective butyrylcholinesterase inhibitors. European Journal of Pharmaceutical Sciences, 47, 190-205.